Review article: Update on current and emergent data on hepatopulmonary syndrome
Open Access
- 28 March 2018
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 24 (12), 1285-1298
- https://doi.org/10.3748/wjg.v24.i12.1285
Abstract
Hepatopulmonary syndrome (HPS) is a frequent pulmonary complication of end-stage liver disease, characterized by impaired arterial oxygenation induced by intrapulmonary vascular dilatation. Its prevalence ranges from 4% to 47% in patients with cirrhosis due to the different diagnostic criteria applied among different studies. Nitric oxide overproduction and angiogenesis seem to be the hallmarks of a complicated pathogenetic mechanism, leading to intrapulmonary shunting and ventilation-perfusion mismatch. A classification of HPS according to the severity of hypoxemia has been suggested. Contrast-enhanced echocardiography represents the gold standard method for the detection of intrapulmonary vascular dilatations which is required, in combination with an elevated alveolar arterial gradient to set the diagnosis. The only effective treatment which can modify the syndrome’s natural history is liver transplantation. Although it is usually asymptomatic, HPS imparts a high risk of pretransplantation mortality, independently of the severity of liver disease, while there is variable data concerning survival rates after liver transplantation. The potential of myocardial involvement in the setting of HPS has also gained increasing interest in recent research. The aim of this review is to critically approach the existing literature of HPS and emphasize unclear points that remain to be unraveled by future research.Keywords
This publication has 132 references indexed in Scilit:
- The role of CX3CL1/CX3CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndromeJournal of Hepatology, 2012
- Left ventricle enlargement and increased systolic velocity in the mitral valve are indirect markers of the hepatopulmonary syndromeLiver International, 2011
- A Central Role for CD68(+) Macrophages in Hepatopulmonary SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Effect of chronic methylene blue administration on hypoxemia in rats with common bile duct ligationHepatology Research, 2010
- Pulmonary Artery Embolotherapy in a Patient with Type I Hepatopulmonary Syndrome after Liver TransplantationKorean Journal of Radiology, 2010
- Pulmonary Angiogenesis in a Rat Model of Hepatopulmonary SyndromeGastroenterology, 2009
- Impact of Hepatopulmonary Syndrome on Quality of Life and Survival in Liver Transplant CandidatesGastroenterology, 2008
- Pilot study of pentoxifylline in hepatopulmonary syndromeLiver Transplantation, 2008
- Hepatopulmonary Syndrome — A Liver-Induced Lung Vascular DisorderThe New England Journal of Medicine, 2008
- Pentoxifylline attenuation of experimental hepatopulmonary syndromeJournal of Applied Physiology, 2007